Sign In
Buy AGEN
$3.07
+0.0300 (+0.99%)
At Close: Jun 23, 2026
Why Agenus Stock Is Slumping This Week
12:21pm, Thursday, 23'rd Mar 2023
Agenus stock has been trending lower ever since the company reported 2022 Q4 earnings last week. Investors appear to be concerned about a possible capital raise.
Penny Stocks To Buy Now: 7 To Watch Before Next Week
11:05am, Friday, 17'th Mar 2023
Are these penny stocks to buy now or avoid entirely? The post Penny Stocks To Buy Now: 7 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Best Penny Stocks To Buy Now: 3 To Watch Before Next Week
04:00pm, Wednesday, 15'th Mar 2023
Penny stocks to watch this week. The post Best Penny Stocks To Buy Now: 3 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Agenus (AGEN) Reports Q4 Loss, Tops Revenue Estimates
09:57am, Tuesday, 14'th Mar 2023
Agenus (AGEN) delivered earnings and revenue surprises of -9.09% and 59.25%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Conference Call Cancelled Conference Call Cancelled
Agenus Schedules Conference Call to Discuss the Company's Minority Cash Holdings at SVB
11:24am, Saturday, 11'th Mar 2023
Conference Call on Monday, March 13, 2023 at 8:30 a.m. ET Conference Call on Monday, March 13, 2023 at 8:30 a.m. ET
LEXINGTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Agenus (Nasdaq: AGEN), a clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infec
Agenus to Participate in February Investor Conferences
07:30am, Thursday, 26'th Jan 2023
LEXINGTON, Mass., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immunological agents targeting cancer and infectious disease, today announced t
Agenus to Present Botensilimab Data at Late-Breaking Oral Session at ASCO-GI
08:30am, Wednesday, 21'st Dec 2022
LEXINGTON, Mass., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancer
7 Hot Stocks to Book Profits In Before 2023
12:55pm, Monday, 19'th Dec 2022
Although a new year tends to bring feelings of optimism, when it comes to the current market dynamics, it's time to consider hot stocks to book profits in before 2023 arrives. At first, circumstances
Agenus: Advancement Of Botensilimab Could Create A Great Pivot Point
05:57am, Tuesday, 13'th Dec 2022
Focus still remains on advancing balstilimab, but instead of just using it alone as a monotherapy against advanced cancers, it is being moved forward together with botensilimab. The phase 2 ACTIVATE p
Agenus: Perpetually Getting There
12:17pm, Monday, 12'th Dec 2022
Agenus Inc. has been around for decades. Many of its molecules have shown promise.
Why Shares of Agenus Rose 12.5% on Friday
04:47pm, Friday, 02'nd Dec 2022
Agenus presented data this week on a combination therapy.
10 Top Penny Stocks With Unusual Options Activity, Time To Buy?
11:39am, Tuesday, 22'nd Nov 2022
Penny stocks to watch with unusual options activity this week. The post 10 Top Penny Stocks With Unusual Options Activity, Time To Buy?
7 Top Penny Stocks With Unusual Options Activity, Time To Buy?
02:15pm, Friday, 18'th Nov 2022
Penny stocks to watch with unusual options activity this week. The post 7 Top Penny Stocks With Unusual Options Activity, Time To Buy?
